DJ Novavax Inc. Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. $(NVAX)$ slid 1.42% to $9.00 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.29% to 51,712.71 and the NASDAQ Composite Index falling 1.32% to 26,166.60.
This was the stock's second consecutive day of losses.
Novavax Inc. closed 24.81% short of its 52-week high of $11.97, which the company reached on February 26th.
The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ rose 1.27% to $231.29, Pfizer Inc. $(PFE)$ fell 0.52% to $25.08, and Merck & Co. Inc. $(MRK)$ rose 1.41% to $115.48.
Trading volume (3.7 M) remained 1.2 million below its 50-day average volume of 4.9 M.
Data source: Dow Jones Market Data, FactSet. Data compiled June 22, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
June 22, 2026 17:28 ET (21:28 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments